Microbot Medical (NASDAQ:MBOT – Get Free Report) will likely be announcing its earnings results before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter.
Microbot Medical Stock Up 3.0 %
Shares of NASDAQ:MBOT opened at $1.71 on Wednesday. The stock has a market cap of $59.41 million, a PE ratio of -2.14 and a beta of 1.60. The business has a 50 day moving average of $1.77 and a 200-day moving average of $1.28. Microbot Medical has a 12-month low of $0.82 and a 12-month high of $3.38.
Wall Street Analyst Weigh In
Separately, HC Wainwright upped their target price on Microbot Medical from $7.00 to $9.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.
About Microbot Medical
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
See Also
- Five stocks we like better than Microbot Medical
- Conference Calls and Individual Investors
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How to invest in marijuana stocks in 7 steps
- 3 Must-Own Stocks to Build Wealth This Decade
- What Are Earnings Reports?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.
